fashion -WSS

fashion

author：entertainment 2025-09-29 01:07:36 - browse：526

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： New chief aims to remake Sanofi Genzyme

focus

leisure time

WSS

How Medicaid coverage policies for immigrants impact new moms

Medicare has a new plan to address drug shortages

Custom gene therapy hints at new path for rare disease treatments

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Biden tests positive for Covid

'The View' co

explore

fashion

explore

ChatGPT in medicine: STAT answers readers' burning questions

Florida babysitter arrested over hot car death, authorities say

Alkermes shareholders re

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Malaria cases in Florida and Texas: Here’s what you need to know

How dance can help nurses traumatized by Covid

Cancer drug shortages should be causing more outrage

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Sports medicine is finally prioritizing gender equality

What is the Turing Test that determines if computers can think?

Wikipedia

STAT Virtual Event: The State of Biosimilars: What to Watch

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Medicare to cover more brain scans for Alzheimer’s patients

Sanders adds drug shortage policies to pandemic preparedness bill

A public scorecard can help hold safety

Biden White House, tech companies launch new safeguards around emerging AI technology

hotspot

focus

leisure time

hotspot